Pharma giant Teva looks to steady ship with new CEO in coming weeks | The Times of Israel
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
Dr. Reddy's: At the helm at Dr. Reddy's, Erez Israeli will have his task cut out - The Economic Times
Teva agrees $519m settlement of US anti-bribery charges | Financial Times
Erez Israeli Net Worth (2022) | wallmine
Dr Reddy's hires former Teva honcho Erez Israeli as COO | The Financial Express
Teva CEO Vigodman steps down as drugmaker seeks direction | The Times of Israel
Teva Hosts UK and Israeli Prime Ministers at UK-Israel Innovation Event – Announce Collaboration on New National Clinical Drug Development Initiative and Dementia Research | Business Wire
Dr. Reddy's COO Erez Israeli elevated as CEO - The Hindu
Inside the big makeover at Dr. Reddy's: Can Erez Israeli pull it off? - The Economic Times
Teva Names Erez Vigodman as President and CEO | Business Wire
Teva beats analysts as Copaxone sales rise - Globes
Erez Israeli – GIC Insights LIVE 2020
Dr. Reddy's Lab announces senior leadership changes
Teva names Vigodman CEO and makes bid for NuPathe - PMLiVE
Teva CEO Erez Vigodman steps down - Philadelphia Business Journal
Teva CEO Erez Vigodman unexpectedly resigns - Globes
Erez Israeli - Chief Executive Officer @ Dr. Reddy's Laboratories - Crunchbase Person Profile
Dr Reddy's names ex-Teva official Erez Israeli as COO, global generics head | Business Standard News